Multiple Sclerosis Market Size, Share & Trends Analysis Report By Drug Type (Immunomodulatory, Immunosuppressant, Interferons, Corticosteroids), By Route of Administration (Oral, Parenteral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR897DR | Pages: 110

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
  7. North America Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. U.S. Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Canada Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  8. Europe Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. U.K. Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Germany Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. France Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. Spain Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Italy Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Russia Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Nordic Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    11. Benelux Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    12. Rest of Europe Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  9. APAC Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. China Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Korea Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Japan Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. India Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Australia Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Singapore Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Taiwan Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    11. South East Asia Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    12. Rest of Asia-Pacific Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  10. Middle East and Africa Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. UAE Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Turkey Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Saudi Arabia Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. South Africa Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Egypt Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Nigeria Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    10. Rest of MEA Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  11. LATAM Multiple Sclerosis Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Immunomodulatory
      2. Immunosuppressant
      3. Interferons
      4. Corticosteroids
    3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
    4. Brazil Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    5. Mexico Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    6. Argentina Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    7. Chile Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    8. Colombia Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
    9. Rest of LATAM Multiple Sclerosis Market Size Analysis
      1. Introduction
      2. Multiple Sclerosis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Immunomodulatory
        2. Immunosuppressant
        3. Interferons
        4. Corticosteroids
      3. Multiple Sclerosis Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
  12. Competitive Landscape
    1. Multiple Sclerosis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Biogen Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Sanofi
    3. GlaxoSmithKline plc.
    4. Celgene Corporation
    5. Pfizer Inc. 
    6. Novartis AG
    7. Teva Pharmaceuticals
    8. Synthetic Biologics Inc.
    9. Bayer AG
    10. Serono Inc.
    11. EMD Opexa Therapeutics Inc.
    12. Active Biotech AB
    13. Merck and Co.
    14. Actelion Pharmaceuticals Ltd.
    15. Innate Immunotherapeutics
    16. InnoBioscience LLC
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: